Physician profile
Ty H Smith
NPI 1992282529
$1,751.14
in general payments reported to CMS, 2019-2025
17 companies · $58.37 in 2025
The $58.37 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $106 · 2021: $266 · 2022: $228 · 2023: $329 · 2024: $422 · 2025: $58.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687 · Entertainment: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.40 |
| Entertainment | $121.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $432.33 | 2019-2023 | Total30 |
| Coopervision INC. | $353.25 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Optos, INC. | $210.08 | 2019-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Eyepoint US, INC. | $134.65 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $125.00 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $95.38 | 2023-2024 | Tyrvaya, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $75.86 | 2023-2024 | Acthar |
| Bausch & Lomb Americas INC. | $50.55 | 2024-2025 | Infuse, Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $48.21 | 2019-2023 | Acuvue |
| Novartis Pharmaceuticals Corporation | $41.58 | 2020-2022 | |
| Harrow Eye, LLC | $39.43 | 2024-2025 | Vevye |
| Allergan, INC. | $37.94 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.71 | 2019-2021 | |
| Shire North American Group INC | $22.06 | 2019 | |
| Eyevance Pharmaceuticals LLC | $18.63 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $18.53 | 2023 | |
| Kala Pharmaceuticals, INC. | $12.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ty Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.